Office of Research & Development |
![]() ![]() |
Project Number: | I01HX002794-01A1 |
Title: | Identifying Best Practices for Medication-Based Suicide Prevention Strategies to Minimize the Risk of Medically-Serious Adverse Events |
Principal Investigator: | Eric G Smith |
Location: | Bedford, MA |
Congressional District Code: | 6 |
Research Service: | Health Services R&D |
Project Period: | April 2020 - March 2023 |
FY 2021 Funding Amount: | $306,505 |
Total Award Amount (all years): |
$930,222 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Background: Lithium (LI) and clozapine (CLOZ) are the most evidence-based medications for preventing fatal and nonfatal suicidal behavior (SB). Unfortunately, both medications also can cause numerous medically serious side effects (SSEs). The VA is conducting a large randomized trial of LI for SB, and VA program offices are considering encouraging greater LI and CLOZ use. This study features a comprehensive database analysis and national survey to gather data to maximize the success of any effor... |